tafenoquine
Commercial- Indications
- Malaria prevention, COVID-19, Fungal infections, Babesiosis
Company intelligence / Profile preview
Scandinavian Biopharma Distribution AB
Solna, Stockholm, Swedenscandinavianbiopharma.se ↗
- Ownership
- Private
- Employees
- ~29
- Development stage
- Commercial
01
Overview
The company has a successful distribution business while also developing the first vaccine for protection against diarrhea caused by ETEC. They recently signed a joint procurement with EU commission to supply diphtheria antitoxin.
- Therapeutic areas
- Infectious Diseases
- Modalities
- VaccinesImmunoglobulins
- Industry
- Biotech
02
Drug pipeline
2 assets1 more asset in the full pipeline.
03
Partnerships
AJ VaccinesKedrionNeoviiFlynn PharmaEmergent BiosolutionsTravel Health GroupUniversity of GothenburgPATHUSAMMDAEuropean Commission's HERA
Beyond the preview
Go deeper on Scandinavian Biopharma Distribution AB.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Scandinavian Biopharma Distribution AB.